This trial is active, not recruiting.

Conditions smoking cessation, copd
Treatments lifestyle counseling and spirometry, smoking cessation advice
Sponsor Jordi Gol i Gurina Foundation
Collaborator Catalan Health Institute
Start date January 2005
End date December 2010
Trial size 466 participants
Trial identifier NCT01296295, Jordi Gol i Gurina Foundation, P10/40.


The purpose of this study is to evaluate the effectiveness of regular reporting of spirometric results combined with smoking cessation advice on smoking quit rate in adult smokers in primary care.

Hypothesis: In adult smokers, regular reporting of spirometric test results in addition with smoking cessation advice will increase smoking quit rate.

Expected outcome: increase of smoking cessation rate .

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose prevention
Intervention group: The intervention is to give brief structured smoking cessation advice combined with a detailed and structured discussion of the spirometric results.
lifestyle counseling and spirometry
The patients of the intervention group will be given a brief structured smoking cessation advice by their primary care physician combined with a detailed and structured discussion of the spirometry results.
(No Intervention)
No intervention group: the patients of the control group will receive a brief structured smoking cessation advice.
smoking cessation advice
Brief smoking cessation advice

Primary Outcomes

Smoking abstinence: self reported abstinence (12 or more months smoking free.
time frame: 24 months after last recruitment

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - All adult smoker population over the age of 18 years attended by their primary care physician for any reason and who do not fulfil exclusion criteria Exclusion Criteria: - Previous diagnosis of COPD by spirometry. - Patients contraindicated to undertake spirometry. - Patients without a telephone. - Patients with communication difficulties: cognitive and/or sensorial deterioration, language. - Patients with severe disease of poor prognosis (life expectancy of less than one year). - Patients with another respiratory disease: asthma, COPD, neoplasm of the respiratory tract, pulmonary thromboembolism, pulmonary tuberculosis, interstitial diseases. - Patients who do not give written informed consent to participate in the study.

Additional Information

Official title Effectiveness of Regular Reporting of Spirometric Results Combined With a Smoking Cessation Advice by a Primary Care Physician on Smoking Quit Rate in Adult Smokers: a Randomized Controlled Trial.
Principal investigator Mar Rodriguez
Description Design: Intervention study with two randomized arms in 5 primary care centers of two health areas. Study population: 466 smokers over the age of 18 consulting their primary care physician for any reason and who do not fulfil the exclusion criteria. Measurements and interventions: The study data will be collected using a structured questionnaire and data collection sheets specifically designed for the study The structured questionnaire will include the following data: sociodemographics, clinical history, smoking habit, respiratory symptomatology, smoking dependence test and smoking cessation motivation test. The data collection sheets will include information related to the spirometric results, peak expiratory flow rate and the carbon monoxide test when performed. On visit 0, the primary care physician will give a brief structured smoking cessation advice to all patients combined with a detailed and structured discussion of the spirometric results. After this visit the patients will be randomised in two arms (control and intervention groups). Randomisation will be performed using a computer programme. Randomisation will be carried out by the Coordinating Centre. Both groups will be followed up by telephone at three (visit 1) and six months (visit 2) and at one-year (visit 3) and two-year(visit 4). During the follow up visits brief structured smoking cessation advice will be reinforced in the control group but the spirometric results will not be discussed. In the intervention group brief structured smoking cessation advice will be reinforced with a detailed structured reminder discussion of the results obtained from the spyrometry of visit 0. Follow up visits 1 and 2 will be undertaken by telephone and the patients will be asked about their smoking habit and will be given a brief questionnaire. One month before visits 3 and 4 both groups will undergo the same series of tests performed prior to visit 0 with the exception of the peak expiratory flow rate. Spirometry will be done only in the intervention group. On visits 3 and 4, the same intervention will be done. On both visits 3 and 4 all the participants who report smoking withdrawal will undergo the carbon monoxide test.
Trial information was received from ClinicalTrials.gov and was last updated in February 2011.
Information provided to ClinicalTrials.gov by Jordi Gol i Gurina Foundation.